Digital Healthcare is fastest growing segment fueling the growth of Rivastigmine market Rivastigmine is a reversible inhibitor of cholinesterase used for the treatment of mild to moderate Alzheimer disease and Parkinsonism. It works by increasing levels of two chemicals, acetylcholine and butyrylcholine, in the brain to help with communication between nerve cells.
The global Rivastigmine Market is estimated to be valued at US$ 516.3 Mn in 2023 and is expected to exhibit a CAGR of...
0 Compartilhamentos
746 Visualizações
0 Anterior